Literature DB >> 27462719

Parameters of Predictive Value in Chronic Myeloid Leukemia-The Prognostic Impact of Histopathological Variables in a Multivariate Regression Analysis.

J Thiele1, H M Kvasnicka1, R Zankovich2, R Fischer1, V Diehl2.   

Abstract

The prognostic significance of disease features at the time of diagnosis was examined in 113 patients (75 males/38 females, median age 49 years) with chronic myeloid leukemia (CML) using multivariate regression analysis. In the course of this study we tested the validity of the prognostic model described by Sokal and coworkers(3), the predictive value of histopathological variables, and determined the disease-specific loss in life expectancy. The median survival time was 35 months in our patients. By using Cox's proportional hazards model for covariate analysis of censored survival data(26)'(32) two prognostic models were derived. The first consisted of the following parameters-age, presence of pseudo-Gaucher cells in the marrow, spleen size and the product of myeloblasts and normoblasts in the peripheral blood. The second model included age, the presence of myelofibrosis, the number of megakaryocytes in the bone marrow and the liver size. Both models provided a risk status that showed an excellent predictive relationship to relative survival rates and life expectancy. Application of the Sokal model(3) to our subpopulation of CML patients failed to reveal a significant segregation of the intermediate group from the other risk groups, even when assessing the disease-specific loss in life expectancy. Our results suggest that an amendment of the generally accepted model for prognostic evaluation of survival in CML should be made by inclusion of histological variables and the determination of relative survival rates.

Entities:  

Keywords:  Chronic myeloid leukemia (CML); Cox models; histological features; life expectancy; prognostic variables

Year:  1991        PMID: 27462719     DOI: 10.3109/10428199109107059

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Prognostic implications of bone marrow features in chronic myelogenous leukaemia.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia.

Authors:  G Büsche; H Majewski; J Schlué; S Delventhal; S Baer-Henney; K F Vykoupil; A Georgii
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

3.  Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow.

Authors:  J Thiele; H M Kvasnicka; B R Titius; U Parpert; R Nebel; R Zankovich; D Dienemann; H Stein; V Diehl; R Fischer
Journal:  Ann Hematol       Date:  1993-06       Impact factor: 3.673

4.  Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies.

Authors:  J Thiele; C Braeckel; S Wagner; B Falini; D Dienemann; H Stein; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

5.  The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia.

Authors:  T Buhr; H Choritz; A Georgii
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Cytogenetics of chronic myelogenous leukemia (CML) correlated to the histopathology of bone marrow biopsies.

Authors:  M Werner; V Kaloutsi; T Buhr; S Delventhal; K F Vykoupil; A Georgii
Journal:  Ann Hematol       Date:  1991-10       Impact factor: 3.673

7.  The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.

Authors:  J Thiele; H M Kvasnicka; N Niederle; T K Zirbes; M Schmidt; J Dammasch; B R Meuter; L D Leder; O Kloke; V Diehl
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.